Conference Coverage

VIDEO: Weighing the cost-effectiveness of contralateral risk-reducing mastectomy


 

EXPERT ANALYSIS FROM MBCC

References

MIAMI – Some researchers suggest contralateral prophylactic mastectomy increases costs, compared with a less-extensive ipsilateral procedure. But if true, the additional cost of the surgery needs to be couched within patient concerns about survival, Dr. Anees Chagpar said at the annual Miami Breast Cancer Conference, held by Physicians’ Education Resource.

The cost-effectiveness can vary based on patient age. In addition, there are costs associated with not undergoing a prophylactic mastectomy that are often not considered, added Dr. Chagpar, director of the Breast Center, Smilow Cancer Hospital at Yale-New Haven (Conn.).

Dr. Chagpar reported no relevant financial disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Stop using radiation therapy in older women, expert says
MDedge Hematology and Oncology
VIDEO: Physicians must counsel women on mastectomy misperceptions
MDedge Hematology and Oncology
VIDEO: Dr. Ann Partridge discusses counseling young breast cancer patients
MDedge Hematology and Oncology
Dose-dense chemotherapy boosts premenopausal breast cancer survival
MDedge Hematology and Oncology
Breast cancer vaccines hold promise
MDedge Hematology and Oncology
VIDEO: Advice varies for chemoprevention, genetic testing in invasive breast cancer
MDedge Hematology and Oncology
VIDEO: Breast cancer surgery choice depends on the individual
MDedge Hematology and Oncology
Review: Use wider margins for DCIS surgery without radiotherapy
MDedge Hematology and Oncology
VIDEO: Counseling patients considering contralateral prophylactic mastectomy
MDedge Hematology and Oncology
VIDEO: Carefully consider impact of MRI to detect contralateral breast cancer
MDedge Hematology and Oncology